RITHIM BIOLOGICS, INC.
Epicardial gene painting catheter for targeted ventricular gene transfer to prevent post-infarction ventricular tachycardia
- Sector
- Medtech
- Total capital
- $1.7M
- Federal grants
- $1.7M
- 3 awards · 2018–2025
- Rank in peer group#470 of 538
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 7 pending · first 2022
- Rank in peer group#237 of 538
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Novel Gene Therapy, Techniques, and Devices to Prevent Ventricular Tachycardia$1.1M
- Federal grantHealth and Human S · Phase II · Novel Gene Therapy, Techniques, and Devices to Prevent Ventricular Tachycardia$317K
- Federal grantHealth and Human S · Phase I · Catheter Development for Epicardial Atrial Gene Painting$260K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 538 peers
Line = medianMedtech · Device
- Federal grantsBelow median
- Granted patents#237 · top 44%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 1 granted of 8- PendingTargeted Drug Delivery Devices And MethodsUSPTOApplication 19439529
- PendingTargeted Drug Delivery Devices And MethodsUSPTOApplication 17638586
- GrantedTargeted Cardiac TherapyUSPTOUS 11,369,773
Show all 8 patent records
- Targeted Drug Delivery Devices And MethodsMay 14, 2026 · Application 19439529Pending
- Targeted Drug Delivery Devices And MethodsSep 15, 2022 · Application 17638586Pending
- Targeted Cardiac TherapyJun 28, 2022 · US 11,369,773Granted
- Targeted Cardiac TherapyJun 16, 2022 · Application 17687737Pending
- Targeted Cardiac TherapyApplication 62445604Pending
- Targeted Drug Delivery Devices And MethodsApplication PCTUS2020048075Pending
- Targeted Drug Delivery Devices And MethodsApplication 62892660Pending
- Targeted Cardiac TherapyApplication PCTUS2018013408Pending
Related companies, and why
- CIRCA BIOSCIENCE LLCSimilar federal contract value in Medtech · null in contracts
- Verthermia Inc.Similar federal contract value in Medtech · null in contracts
- DYAD MEDICAL, INC.Similar federal contract value in Medtech · null in contracts
- GREEN APPLE TECHNOLOGIES, LLCSimilar federal contract value in Medtech · null in contracts
- VERDURE IMAGING, INC.Similar federal contract value in Medtech · null in contracts
- DATA DRIVEN BIOSCIENCE INCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .